In a rat model with multiple cardiovascular risk factors, including hypertension, diabetes, obesity, and hyperlipidemia, in vivo Klotho gene delivery can ameliorate vascular endothelial dysfunction [12]. This evidence concerns the gene KL and obesity due to melanocortin 4 receptor deficiency.